# CHAPTER 12: FUTURE WORK

## 12.1 Overview
The current research establishes a strong foundation for AI-based jaundice detection. Future efforts should focus on enhancing robustness, clinical integration, and accessibility.

## 12.2 Model and Algorithm Improvements
-   **Hybrid Segmentation-Classification Models**: Future work could explore the use of Vision Transformers (ViTs) or Attention-U-Net variants that can focus specifically on the most diseased regions of the sclera.
-   **Generative Data Augmentation**: Utilizing Generative Adversarial Networks (GANs) to generate synthetic images of jaundiced eyes under various lighting conditions could help in further balancing the dataset and improving model robustness.
-   **Temporal Analysis**: Developing models that can track jaundice progression over time for a single patient could provide valuable data for monitoring treatment efficacy.

## 12.3 Multi-Modal Diagnostics
Integrating sclera image analysis with other non-invasive markers—such as image-based nail bed analysis or breath analysis for volatile organic compounds—could lead to a comprehensive, multi-modal screening platform with significantly higher diagnostic accuracy.

## 12.4 Mobile Application Development
The current Streamlit interface can be evolved into a cross-platform mobile application. Using native camera APIs, the app could guide users through the image capture process to ensure optimal lighting and framing, significantly reducing user error and improving data quality for home-based screening.

## 12.5 Clinical Integration and Large-Scale Trials
The most critical follow-up is the conduct of a large-scale, multi-hospital clinical trial. Integrating the system with Hospital Information Systems (HIS) would allow for real-time validation against laboratory reports, paving the way for regulatory approval (e.g., FDA or CE certification) for use in telemedicine.
